4//SEC Filing
Dipexium Pharmaceuticals, Inc. 4
Accession 0001104659-16-090798
CIK 0001497504operating
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 3:19 PM ET
Size
5.2 KB
Accession
0001104659-16-090798
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident, CEO, Secretary10% Owner
Transactions
- Award
Options
2016-01-19$10.16/sh+35,000$355,600→ 35,000 totalExercise: $10.16Exp: 2026-01-19→ Common stock, $0.001 par value per share (35,000 underlying)
Footnotes (1)
- [F1]Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period.
Documents
Issuer
Dipexium Pharmaceuticals, Inc.
CIK 0001497504
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001497504
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 3:19 PM ET
- Size
- 5.2 KB